Regulatory

Clinical Trials as Revenue Drivers: Interview with Matthew Amsden, CEO of ProofPilot

In this episode of Medsider Radio, our guest is Matthew Amsden, the Founder and CEO of ProofPilot, a platform designed to help people design, launch and participate in clinical trials.

ProofPilot’s mission statement revolves around making it incredibly easy to run scientifically-valid research studies. They’re dedicated to making research study participation accessible, interesting, and fun.

In this discussion with Matthew, we chatted about the importance and feasibility of virtual clinical trials, how they can potentially become a revenue driver, the origin story of ProofPilot, and why their hybrid model is so popular.

Interview Highlights with Matthew Amsden

  • Who is Matthew Amsden and where did the idea for ProofPilot begin?
  • Why clinical trials are important and how to make them feasible for healthcare companies.
  • The importance of letting early customers try product iterations.
  • How clinical studies can become a revenue driver instead of a cost center.
  • Various types of clinical trials and how they’re conducted on the ProofPilot platform.
  • Risky and costly approaches to traditional clinical studies.
  • The synergy between data, compliance, and incentives.
  • How a virtual, hybrid model can solve problems when it comes to traditional clinical trials.
  • Matthew’s favorite business book, the mentor he most admires, and the advice he’d give to his 30-year-old-self.

Listen to the Interview with Matthew Amsden

Read the Interview with Matthew Amsden

Download a copy of the interview transcript right here.

You May Like These Articles

  • Recent
  • Featured
  • Related

Key Lessons for Developing an Insurance Coverage and Reimbursement Strategy: Interview with Mike Kujak, CEO of Francis Medical

In this interview with Mike Kujak, CEO of Francis Medical, he offers advice about navigating the early-stage medtech regulatory and reimbursement environments.

How to Position Your Medtech Start-Up for an Exit: Interview with Bruce Shook, CEO of Vesper Medical

In this conversation with Bruce Shook, CEO of Vesper Medical, we’ll discuss key aspects of running a medtech company, from the early design and fundraising stages through an eventual sale and exit.

The Most Important Piece of Advice for Raising Medtech Venture Capital: Interview with Sean Saint, Founder of Companion Medical

In this interview with Sean Saint, CEO of Companion Medical, we covered his journey from the inception of the InPen to their eventual exit to Medtronic.

How to Win with Contract Manufacturers: Interview with Travis Sessions, CEO of Biomerics

In this interview with Travis Sessions, CEO of Biomerics and Managing Partner of Med Venture Holdings, we discuss critical things to look for when identifying and working with contract manufacturers.

Conquering the Coverage and Reimbursement Landscape: Interview with Bruce Shook, President of Intact Vascular

In this interview, Bruce Shook discusses medical device insurance coverage and reimbursement, as well as advice for other healthcare entrepreneurs that need to raise money.

Why Curiosity and Persistence are Crucial Characteristics for Medtech Entrepreneurs: Interview with the Legendary Dr. John Simpson, Executive Chairman of Avinger

In this interview, the legendary Dr. John Simpson shares what drew him to the field of cardiology, his approach to building a medtech team, and why knowing your strengths and limitations is key to making a difference in the lives of others.

After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics

In this interview with Duke Rohen, he discusses how he successfully led two early-stage medtech companies at the same time and the major lessons he learned raising money for 4 different medical device companies.

Having a Heart Attack? There’s an App for That! The Incredible Story of How Dr. David Albert Brought the ECG iPhone App to Market

In this interview with Dr. David Albert, we learn about his incredible journey in bringing the first iPhone ECG app to market with AliveCor.

Clinical Trials as Revenue Drivers: Interview with Matthew Amsden, CEO of ProofPilot

In this discussion with Matthew Amsden, learn about the importance and feasibility of virtual clinical trials, how they can potentially become a revenue driver, the origin story of ProofPilot, and why their hybrid model is so popular.

How Remote Testing Can Change the Game for Patients and Clinicians: Interview with Katherine Ward of Healthy.io

In this conversation with Katherine Ward, we cover what Healthy.io does for the broader healthcare community, lessons from the COVID-19 crisis, and the value of decentralized remote diagnostic screening.

Is Off-Label Promotion Now Legal: What the Recent Criminal Case Against Vascular Solutions Means for Medtech

In this interview, Mark Duval discusses why the government's focus on speech vs. conduct is important when it comes to medical device off-label promotion.

Social Media Best Practices for Marketing Medical Devices: Interview with Dr. Mukesh Kumar

In this interview with Dr. Mukesh Kumar, we learn about common misconceptions around the use of social media to market and sell FDA-regulated medical devices.

Success! Your membership is now active.